Recent advances in discovering the role of CCL5 in metastatic breast cancer

Ayesha Khalid, Joy Wolfram, Ilaria Ferrari, Chaofeng Mu, Junhua Mai, Zhizhou Yang, Yuliang Zhao, Mauro Ferrari, Xiaojing Ma, Haifa Shen

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

A variety of therapeutic strategies are currently under investigation to inhibit factors that promote tumor invasion, as metastasis is the most common cause of mortality for cancer patients. Notably, considerable emphasis has been placed on studying metastasis as a dynamic process that is highly dependent on the tumor microenvironment. In regards to breast cancer, chemokine C-C motif ligand 5 (CCL5), which is produced by tumor-associated stromal cells, has been established as an important contributor to metastatic disease. This review summarizes recent discoveries uncovering the role of this chemokine in breast cancer metastasis, including conditions that increase the generation of CCL5 and effects induced by this signaling pathway. In particular, CCL-5-mediated cancer cell migration and invasion are discussed in the context of intertwined feedback loops between breast cancer cells and stromal cells. Moreover, the potential use of CCL5 and its receptor chemokine C-C motif receptor 5 (CCR5) as targets for preventing breast cancer metastasis is also reviewed.

Original languageEnglish (US)
Pages (from-to)1063-1072
Number of pages10
JournalMini-Reviews in Medicinal Chemistry
Volume15
Issue number13
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Ligands
Stromal Cells
Neoplasms
CCR Receptors
CC Chemokines
Tumor Microenvironment
Chemokines
Cell Movement
Mortality
Therapeutics

Keywords

  • Breast cancer
  • CCL5
  • CCR5
  • Mesenchymal stem cells
  • Metastasis
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Khalid, A., Wolfram, J., Ferrari, I., Mu, C., Mai, J., Yang, Z., ... Shen, H. (2015). Recent advances in discovering the role of CCL5 in metastatic breast cancer. Mini-Reviews in Medicinal Chemistry, 15(13), 1063-1072.

Recent advances in discovering the role of CCL5 in metastatic breast cancer. / Khalid, Ayesha; Wolfram, Joy; Ferrari, Ilaria; Mu, Chaofeng; Mai, Junhua; Yang, Zhizhou; Zhao, Yuliang; Ferrari, Mauro; Ma, Xiaojing; Shen, Haifa.

In: Mini-Reviews in Medicinal Chemistry, Vol. 15, No. 13, 01.10.2015, p. 1063-1072.

Research output: Contribution to journalReview article

Khalid, A, Wolfram, J, Ferrari, I, Mu, C, Mai, J, Yang, Z, Zhao, Y, Ferrari, M, Ma, X & Shen, H 2015, 'Recent advances in discovering the role of CCL5 in metastatic breast cancer', Mini-Reviews in Medicinal Chemistry, vol. 15, no. 13, pp. 1063-1072.
Khalid, Ayesha ; Wolfram, Joy ; Ferrari, Ilaria ; Mu, Chaofeng ; Mai, Junhua ; Yang, Zhizhou ; Zhao, Yuliang ; Ferrari, Mauro ; Ma, Xiaojing ; Shen, Haifa. / Recent advances in discovering the role of CCL5 in metastatic breast cancer. In: Mini-Reviews in Medicinal Chemistry. 2015 ; Vol. 15, No. 13. pp. 1063-1072.
@article{2d2af4a7d7c04a389177850df1149cd6,
title = "Recent advances in discovering the role of CCL5 in metastatic breast cancer",
abstract = "A variety of therapeutic strategies are currently under investigation to inhibit factors that promote tumor invasion, as metastasis is the most common cause of mortality for cancer patients. Notably, considerable emphasis has been placed on studying metastasis as a dynamic process that is highly dependent on the tumor microenvironment. In regards to breast cancer, chemokine C-C motif ligand 5 (CCL5), which is produced by tumor-associated stromal cells, has been established as an important contributor to metastatic disease. This review summarizes recent discoveries uncovering the role of this chemokine in breast cancer metastasis, including conditions that increase the generation of CCL5 and effects induced by this signaling pathway. In particular, CCL-5-mediated cancer cell migration and invasion are discussed in the context of intertwined feedback loops between breast cancer cells and stromal cells. Moreover, the potential use of CCL5 and its receptor chemokine C-C motif receptor 5 (CCR5) as targets for preventing breast cancer metastasis is also reviewed.",
keywords = "Breast cancer, CCL5, CCR5, Mesenchymal stem cells, Metastasis, Triple-negative breast cancer",
author = "Ayesha Khalid and Joy Wolfram and Ilaria Ferrari and Chaofeng Mu and Junhua Mai and Zhizhou Yang and Yuliang Zhao and Mauro Ferrari and Xiaojing Ma and Haifa Shen",
year = "2015",
month = "10",
day = "1",
language = "English (US)",
volume = "15",
pages = "1063--1072",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "13",

}

TY - JOUR

T1 - Recent advances in discovering the role of CCL5 in metastatic breast cancer

AU - Khalid, Ayesha

AU - Wolfram, Joy

AU - Ferrari, Ilaria

AU - Mu, Chaofeng

AU - Mai, Junhua

AU - Yang, Zhizhou

AU - Zhao, Yuliang

AU - Ferrari, Mauro

AU - Ma, Xiaojing

AU - Shen, Haifa

PY - 2015/10/1

Y1 - 2015/10/1

N2 - A variety of therapeutic strategies are currently under investigation to inhibit factors that promote tumor invasion, as metastasis is the most common cause of mortality for cancer patients. Notably, considerable emphasis has been placed on studying metastasis as a dynamic process that is highly dependent on the tumor microenvironment. In regards to breast cancer, chemokine C-C motif ligand 5 (CCL5), which is produced by tumor-associated stromal cells, has been established as an important contributor to metastatic disease. This review summarizes recent discoveries uncovering the role of this chemokine in breast cancer metastasis, including conditions that increase the generation of CCL5 and effects induced by this signaling pathway. In particular, CCL-5-mediated cancer cell migration and invasion are discussed in the context of intertwined feedback loops between breast cancer cells and stromal cells. Moreover, the potential use of CCL5 and its receptor chemokine C-C motif receptor 5 (CCR5) as targets for preventing breast cancer metastasis is also reviewed.

AB - A variety of therapeutic strategies are currently under investigation to inhibit factors that promote tumor invasion, as metastasis is the most common cause of mortality for cancer patients. Notably, considerable emphasis has been placed on studying metastasis as a dynamic process that is highly dependent on the tumor microenvironment. In regards to breast cancer, chemokine C-C motif ligand 5 (CCL5), which is produced by tumor-associated stromal cells, has been established as an important contributor to metastatic disease. This review summarizes recent discoveries uncovering the role of this chemokine in breast cancer metastasis, including conditions that increase the generation of CCL5 and effects induced by this signaling pathway. In particular, CCL-5-mediated cancer cell migration and invasion are discussed in the context of intertwined feedback loops between breast cancer cells and stromal cells. Moreover, the potential use of CCL5 and its receptor chemokine C-C motif receptor 5 (CCR5) as targets for preventing breast cancer metastasis is also reviewed.

KW - Breast cancer

KW - CCL5

KW - CCR5

KW - Mesenchymal stem cells

KW - Metastasis

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84947732951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947732951&partnerID=8YFLogxK

M3 - Review article

C2 - 26420723

AN - SCOPUS:84947732951

VL - 15

SP - 1063

EP - 1072

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 13

ER -